Institutional Ownership Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE). We have compiled data on the 167 institutions that hold shares in the stock, with a total of 101 Million shares, which have been reported (via 13F filing form) to have a value of $173 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Redmile Group, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
12,872,946
shares
|
$20 Million
1.66% of portfolio
|
Q4 2024
Reduced 2.25%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
10,333,033
shares
|
$16 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.68%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,116,106
shares
|
$15.7 Million
0.0% of portfolio
|
Q2 2024
Added 11.17%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
4,839,779
shares
|
$7.5 Million
0.16% of portfolio
|
Q1 2024
Reduced 0.24%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
4,382,257
shares
|
$6.79 Million
0.0% of portfolio
|
Q4 2024
Added 2.34%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Feb 14, 2025 Q4 2024 |
3,555,871
shares
|
$5.51 Million
0.15% of portfolio
|
Q2 2024
Added 62.34%
|
|
|
Johnson & Johnson
New Brunswick, NJ |
Feb 13, 2025 Q4 2024 |
3,379,064
shares
|
$5.24 Million
1.9% of portfolio
|
Q3 2021
New holding
|
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,258,402
shares
|
$5.05 Million
0.06% of portfolio
|
Q4 2024
Added 8.69%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
3,049,405
shares
|
$4.73 Million
0.24% of portfolio
|
Q4 2024
New holding
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
2,898,377
shares
|
$4.49 Million
0.0% of portfolio
|
Q4 2024
Added 10.67%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
2,822,183
shares
|
$4.37 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.87%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,476,414
shares
|
$3.84 Million
0.0% of portfolio
|
Q4 2024
Reduced 12.29%
|
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,465,000
shares
|
$3.82 Million
0.24% of portfolio
|
Q4 2024
Added 46.29%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,227,295
shares
|
$3.45 Million
0.0% of portfolio
|
Q4 2024
Reduced 57.6%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,226,967
shares
|
$3.45 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.39%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
1,855,954
shares
|
$2.88 Million
0.23% of portfolio
|
Q4 2024
Added 165.14%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
1,680,580
shares
|
$2.6 Million
0.08% of portfolio
|
Q3 2024
Added 24.0%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,669,562
shares
|
$2.59 Million
0.0% of portfolio
|
Q4 2024
Reduced 9.13%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
1,586,987
shares
|
$2.46 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.06%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
1,536,633
shares
|
$2.38 Million
0.0% of portfolio
|
Q4 2024
Reduced 54.51%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
1,473,792
shares
|
$2.28 Million
0.01% of portfolio
|
Q4 2024
Reduced 8.01%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,422,785
shares
|
$2.21 Million
0.02% of portfolio
|
Q4 2024
Reduced 53.59%
|
|
|
Superstring Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,379,556
shares
|
$2.14 Million
1.97% of portfolio
|
Q4 2024
Reduced 5.96%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,103,393
shares
|
$1.71 Million
0.0% of portfolio
|
Q4 2024
Added 172.93%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,090,260
shares
|
$1.69 Million
0.01% of portfolio
|
Q2 2023
Reduced 9.09%
|